Targeting Highly Reactive Oxygen Species (hROS) for Prodrug Activation through a Cascade Reaction with Kinetic Tunability (CReKT) to Effect Linker Cleavage

18 December 2025, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

Because of the association of various pathological conditions with the over-production of reactive oxygen species (ROS), there is a strong interest in ROS-sensitive linker chemistry for drug delivery and other applications. Most ROS-sensitive cleavable linkers rely on their broad reactivity toward all ROS including the least reactive ROS, hydrogen peroxide, and highly reactive oxygen species (hROS) such as hypochlorite, peroxynitrite, and hydroxy radical. However, individual ROS has very specialized functions and unique roles in various pathologies. Therefore, there is a need for species-selective activation chemistry for drug delivery applications. OCl- is the second most abundant ROS and primarily produced in response to infection and/or inflammation by certain immune cells that express myeloperoxidase (MPO). We herein describe a novel hROS-selective prodrug approach through a OCl--initiated Cascade Reaction with Kinetic Tunability (CReKT) for drug release. Specifically, ClO- oxidation of a phenylthioether is used to create a cleavable event, via enhancing the nucleophilicity of the S-connected carbon for condensation-based payload release. The reactivity of the S-connected carbon is further augmented by tethering to an electron-withdrawing group (EWG) and by creating synergy with proximity effects. Tunability of release kinetics can be achieved by varying the EWG, substitution on the phenyl ring, and entropic factors. This approach has four key features: (1) stable prodrugs, (2) selectivity for hypochlorite-activation, (3) tunability in release kinetics, and (4) free of labile metal- or boron-based groups. This approach affords new tools and sets a new direction in designing species-selective ROS-sensitive prodrugs.

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Additional materials and methods and experimental details including HPLC traces and studies, LCMS study, cyclization studies, cytotoxicity studies, NMR and HRMS spectrum of compounds.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.